Bi-Specific shRNA that Simultaneously Downregulates mTOR & STAT3

Time: 3:00 pm
day: Day Two


  • Introducing a new approach for RNAi therapy using Bi-specific shRNA
  • Using our bioinformatic platform to determine prominent genes in specific diseases such as mTOR and STAT3 genes in cancer
  • Determine the therapeutic effect of naked Bi-specific shRNA vs using a viral carrier for Bi-specific shRNA